Table 4.
Comparison of surgical outcomes.
| Transvesical approach (n = 44) | Posterior approach (n = 52) | p | |
|---|---|---|---|
| Oncology: postoperative total PSA, ng/mL, mean (SD) | |||
| Postoperative 1 week | 2.133 (1.914) | 2.358 (1.537) | 0.526 |
| Postoperative 12 months | 0.046 (0.029) | 0.051 (0.025) | 0.308 |
| Urinary continence | |||
| Continent on removal of catheter, n (%) | 40 (90.9%) | 46 (88.5%) | 0.750 |
| Continent at postoperative 3 months, n (%) | 44 (100%) | 52 (100%) | – |
| Continent at postoperative 12 months, n (%) | 44 (100%) | 52 (100%) | – |
| Erectile function, median (IQR) | |||
| IIEF-5 score at postoperative 3 months | 15 (10, 18) | 14 (9, 17) | 0.431 |
| IIEF-5 score at postoperative 12 months | 14 (10, 16) | 13 (9,15) | 0.458 |
SD, standard deviation; IQR, interquartile range.